CS
ANNX icon

Candriam SCA’s Annexon ANNX Stock Holding History

Candriam SCA’s Portfolio ANNX Stock Details ANNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,534,230
Closed -$7.73M – 688
2025
Q3 		$7.73M Hold
2,534,230
– – 0.04% 305
2025
Q2 		$6.08M Hold
2,534,230
– – 0.04% 322
2025
Q1 		$4.89M Hold
2,534,230
– – 0.03% 334
2024
Q4 		$13M Buy
2,534,230
+341,431
+16% +$2.1M 0.07% 225
2024
Q3 		$13M Buy
2,192,799
+139,340
+7% +$826K 0.07% 235
2024
Q2 		$10.1M Buy
+2,053,459
New +$10.6M 0.06% 251
2023
Q1 		– Sell
-164,558
Closed -$851K – 879
2022
Q4 		$851K Sell
164,558
-992
-0.6% -$5.45K 0.01% 734
2022
Q3 		$1.02M Buy
+165,550
New +$895K 0.01% 699

Other funds holding ANNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Candriam SCA's ANNX Position: Q4 2025 in Review

Candriam SCA sold out of Annexon (ANNX) in Q4 2025, closing a stake of 2,534,230 shares — an estimated $7.73M sold.

Candriam SCA first reported a position in ANNX in Q3 2022 and held it in 8 quarters. The position peaked at $13M in Q4 2024. 168 funds tracked by Wall St. Rank hold ANNX as of Q4 2025.

  • Candriam SCA reported no remaining Annexon position as of Q4 2025 after selling out during the quarter.
  • Candriam SCA sold 2,534,230 Annexon shares in Q4 2025, an estimated $7.73M.
  • Candriam SCA first reported a position in Annexon in Q3 2022 and held it in 8 quarters.
  • Candriam SCA's Annexon position peaked at $13M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Annexon as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.